![These highlights do not include all the information needed to use DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017 These highlights do not include all the information needed to use DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=dupixent-61.jpg&id=735399)
These highlights do not include all the information needed to use DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017
![Dupixent Syringe Dupilumab 300 mg / 2 mL Injection Prefilled Syringe 2 — Mountainside Medical Equipment Dupixent Syringe Dupilumab 300 mg / 2 mL Injection Prefilled Syringe 2 — Mountainside Medical Equipment](https://www.mountainside-medical.com/cdn/shop/products/Dupixent-Syringe--Dupilumab-300-mg--2-mL-Injection-Prefilled-Syringe-2-mL-NDC--00024-5914-01.jpg?v=1673032881)
Dupixent Syringe Dupilumab 300 mg / 2 mL Injection Prefilled Syringe 2 — Mountainside Medical Equipment
![These highlights do not include all the information needed to use DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017 These highlights do not include all the information needed to use DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=dupixent-42.jpg&id=735399)
These highlights do not include all the information needed to use DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017
![European Commission approves Dupixent (dupilumab), the first drug for the treatment of prurigo nodularis_Hong Kong Magicure Medical Center European Commission approves Dupixent (dupilumab), the first drug for the treatment of prurigo nodularis_Hong Kong Magicure Medical Center](http://en.hkmagicure.com/uploads/allimg/221216/1-2212161GS60-L.jpg)